HRT Financial’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

HRT Financial’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30,943	Closed	-$16K	–	3624
2024 Q4	$16K	Buy	+30,943	New	+$21.6K	﹤0.01%	2241
2024 Q3	–	Sell	-36,716	Closed	-$42K	–	3389
2024 Q2	$42K	Buy	+36,716	New	+$91.9K	﹤0.01%	1857
2023 Q2	–	Sell	-152,410	Closed	-$1.05M	–	3506
2023 Q1	$1.05M	Buy	+152,410	New	+$956K	0.01%	920
2022 Q3	–	Sell	-26,408	Closed	-$127K	–	3693
2022 Q2	$127K	Buy	+26,408	New	+$161K	﹤0.01%	2378

HRT Financial's MRNS Position: Q1 2025 in Review

HRT Financial sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 30,943 shares — an estimated $16K sold.

HRT Financial first reported a position in MRNS in Q2 2022 and held it in 4 quarters. The position peaked at $1.05M in Q1 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

HRT Financial reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
HRT Financial sold 30,943 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $16K.
HRT Financial first reported a position in Marinus Pharmaceuticals, Inc in Q2 2022 and held it in 4 quarters.
HRT Financial's Marinus Pharmaceuticals, Inc position peaked at $1.05M in Q1 2023.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.